Epstein-Barr virus DNA in serum after liver transplantation - surveillance of viral activity during treatment with different immunosuppressive agents

Transplant International

Volumn 9, Issue 5, 1996, Pages 439-445

  Barkholt, L M ^a   Dahl, H ^b,c   Enbom, M ^b   Linde A ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Virology   (Sweden)

Author keywords

Epstein Barr virus; Immunosuppression liver transplantation; Immunosuppression virus DNA; Liver transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; OKT 3; STEROID; TACROLIMUS; VIRUS ANTIBODY; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BRAIN LYMPHOMA; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MONITORING; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0029758042     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb00986.x     Document Type: Article

References (35)

1. Barkholt L, Billing H, Juliusson G, Porwit A, Ericzon BG, Groth CG (1991) B-cell lymphoma in transplanted liver. Clinical, histological and radiological manifestations. Transpl Int 4: 8-11
2. Barkholt L, Ericzon B-G, Tollemar J, Malmborg A-S, Ehrnst A, Wilczek H, Andersson J (1993) Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int 6: 77-84
3. Bryttinger M, Xu W, Wahren B, Sundqvist V (1992) Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol 30: 1937-1941
4. Burman K, Crawford DH (1991) Effect of FK506 on Epstein-Barr virus specific cytotoxic T-cells. Lancet 337: 297-298
5. Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N, Manforte AA, Wahren B, Lazzarin A, Linde A (1993) Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342: 398-401
6. Cohen KI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency Proc Natl Acad Sci USA 86: 9558-9561
7. Crawford DH, Edwards JMB, Sweny P, Janossy G, Hoffbrand AV (1981) Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet I: 10-12
8. European FK506 multicenter liver study group (1994) Randomised trial comparing Tacrolimus (FK506) and Cyclosporin in prevention of liver allograft rejection. Lancet 344: 423-428
9. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL (1989) Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 2: 583-592
10. Gan Y-J, Sullivan JL, Sixbey JW (1994) Detection of cell-free Epstein-Barr virus DNA in serum during active infectious mononucleosis. J Infect Dis 170: 436-439
11. Hara K, Kohno S, Koga H, Kaku M, Tomono K, Sakata S, Komatsu K, Omagari K (1995) Infections in patients with liver cirrhosis and hepatocellular carcinoma. Intern Med 34: 491-495
12. Jawetz E, Melnick JL, Adelberg EA (1991) Herpes virues. In: Jawetz E, Melnick JL, Adelberg EA (eds) Medical microbiology. Prentice-Hall International, East Norwalk, Connecticut, pp 418-440
13. Levine PH, Ebbesen P, Ablashi DV, Saxiner WC, Nordentoft A, Connelly R (1992) Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer 51: 53-57
14. Linde A. Andersson J, Lundgren G, Wahren B (1987) Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol 21: 109-121
15. Linde A, Kallin B, Dillner J, Andersson J, Jägdahl L, Lindvall A, Wahren B (1990) Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis 161: 903-909
16. Marsano L, Perillo RP, Flye MW, Hanto DW, Soitzer ED, Thomas JR, Murray PR, Windus DW, Brant EM, Storch GA (1990) Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 161: 454-461
17. Masucci MG, Ernberg I (1994) Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol Rev 2: 125-130
18. McDiarmid SV, Busuttil RW, Levy P, Millis MJ, Terasaki PI, Ament ME (1991) The long-term outcome of OKT3 compared with cyclosporin prophylaxis after liver transplantation. Transplantation 52: 91-97
19. Nalesnik MA, Makowka L, Starzl TE (1988) Diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg 25: 365-472
20. Nyberg G, Bergström T, Blohmé I, Nordén G, Olofsson S, Ricksten A (1994) Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white cells and serum. Transpl Int 7: 428-433
21. Penn I (1993) Epstein-Barr virus-associated disorders in transplant patients. Literature Scan Transplant 9: 30-32
22. Randhawa PS, Markin RS, Starzl TE, Demetris AJ (1990) Epstein-Barr virus-associated syndromes after liver transplantation. Am J Surg Pathol 14: 538-547
23. Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D, Preiksaitis J, Merigan TC (1982) Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects with cytomegalovirus. J Infect Dis 2: 191-199
24. Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Ganbdjbakhch I, Suberbielle C, Farcet JP, Raphael M (1994) Patterns of Epstein-Barr virus latent and proliferative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 58: 317-324
25. Renard TH, Andrews WS, Foster ME (1991) Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 23: 1473-1476
26. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE (1995) Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 89: 98-103
27. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P (1995) Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171: 273-280
28. Singh N, Gayowski T, Wagener M, Yu VL (1994) Infectious complications in liver transplant recipients on Tacrolimus. Transplantation 58: 774-778
29. Snover DC, Freece DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL (1987) Liver allograft rejection: an analysis of the use of biopsy in determining the outcome of rejection. Am J Surg PathoI 11: 1-10
30. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet I: 583-587
31. Svedmyr E, Ernberger I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G (1984) Virologic, immunologic, and clinical observations on a patient during the incubation, acute and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30: 437-450
32. Swinnen LJ, Costanzo-Nordin MR, Fisher Su, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI (1990) Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323: 1723-1728
33. Telenti A, Smith TD, Ludwig F, Keating MR, Krom RAF, Wiesner RH (1991) Epstein-Barr virus and persistent graft dysfunction after liver transplantation. Hepatology 14: 282-286
34. The U.S. Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115
35. 1994 Annual Report of the U. S. Scientific Registry for Transplantation Recipients and the Organ Procurement and Transplantation Network - Transplant Data, 1988-1993. UNOS Richmond, VA and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Bethesda, MD, USA